stockrow
Friday 6 November 2026
Export PRVA’s income statement to Excel — free account
Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
24.32
0.38
+1.59%
Follow PRVA
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 5 | — | — | — | — | — |
P/E ratio |
131.72 | 150.38 | 124.79 | 0.00 | 0.00 | 70.42 | 70.42 | 70.42 | — |
Altman Z-Score |
4.78 | 4.86 | 5.94 | 7.19 | 7.15 | — | — | — | — |
P/S ratio |
1.36 | 1.34 | 1.67 | 1.82 | 2.76 | 2.70 | 2.70 | 2.70 | — |
Altman Z″-Score (non-manufacturers) |
2.87 | 3.40 | 3.19 | 3.32 | 1.33 | 2.00 | — | — | — |
P/FCF ratio |
17.76 | 21.42 | 34.38 | 52.40 | 48.86 | 51.21 | 51.21 | 51.21 | — |
Beneish M-Score |
(2.59) | (2.89) | (2.35) | (2.51) | (4.22) | — | — | — | — |
P/Operating CF |
22.72 | 31.21 | 43.18 | 84.63 | (216.18) | (891.63) | (891.63) | (891.63) | — |
P/B ratio |
3.66 | 3.42 | 4.56 | 4.75 | 5.92 | 14.78 | 14.78 | 14.78 | — |
Price to Tangible BV |
7.93 | 5.40 | 7.67 | 7.37 | 10.15 | 88.71 | 88.71 | 88.71 | — |
EV/Sales |
1.15 | 1.08 | 1.45 | 1.59 | 2.46 | 2.64 | 2.64 | 2.64 | — |
EV/EBITDA |
55.47 | 77.31 | 88.65 | 0.00 | 0.00 | 74.73 | 74.73 | 74.73 | — |
EV/Operating CF |
14.99 | 17.15 | 29.83 | 45.57 | 43.13 | 49.62 | 49.62 | 49.62 | — |
EV/FCF |
15.01 | 17.20 | 29.94 | 45.67 | 43.56 | 50.05 | 50.05 | 50.05 | — |
Quick Ratio |
1.55 | 1.80 | 1.76 | 2.03 | 2.30 | 1.25 | 1.08 | — | — |
Current Ratio |
1.60 | 1.86 | 1.81 | 2.09 | 2.35 | 1.29 | 1.12 | — | — |
Net Debt/EBITDA |
(10.87) | (20.25) | (14.33) | 25.10 | 1.34 | (1.90) | (0.40) | 0.00 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 4.62% | 9.97% | 0.00% | — | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.23 | 0.00 | — | — |
Asset Turnover |
1.69 | 1.63 | 1.85 | 1.83 | 1.90 | 4.97 | 0.00 | 0.00 | — |
Operating CF/Net income |
7.13 | 7.60 | 3.50 | (5.50) | (0.29) | 1.24 | 2.95 | (1.75) | — |
Capex/Depreciation |
0.00 | 0.00 | (0.02) | (0.02) | (0.21) | (0.19) | (3.25) | 0.00 | — |
Interest Coverage |
— | — | (2.47) | 35.28 | (203.21) | 13.24 | 2.32 | 0.67 | — |
| 3.11% | 2.23% | 4.10% | (1.77%) | (63.39%) | 24.61% | 6.42% | 0.00% | — | |
| 1.83% | 1.35% | 2.57% | (1.16%) | (37.08%) | 19.00% | 0.00% | 0.00% | — | |
ROIC |
6.87% | 5.52% | 5.92% | (6.99%) | (84.26%) | 17.28% | 0.00% | — | — |
Return on Tangible Assets |
6.68% | 3.72% | 7.30% | (2.95%) | (72.20%) | 65.15% | 41.22% | 0.00% | — |
Average Days of Receivables |
68.93 | 66.46 | 64.02 | 51.01 | 44.35 | 44.28 | 35.90 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
7.79% | 8.79% | 8.10% | 11.01% | 28.84% | 6.78% | 6.48% | 8.05% | — |
Intangible Assets out of Total Assets |
0.31 | 0.22 | 0.25 | 0.23 | 0.27 | 0.38 | 0.00 | — | 0.00 |
Share Based Compensation of Revenue |
3.35% | 3.26% | 2.24% | 4.97% | 26.24% | 0.06% | 0.03% | 0.00% | — |
Graham Net Nets |
0.11 | 0.16 | 0.11 | 0.11 | 0.08 | 0.00 | 0.00 | 0.00 | — |
Graham Number |
5.12 | 4.09 | 4.72 | 0.00 | 0.00 | 3.29 | 0.00 | 0.00 | — |
Earnings Yield |
0.76% | 0.66% | 0.80% | (0.40%) | (7.04%) | 1.42% | 1.42% | 1.42% | — |
Free Cash Flow Yield |
5.63% | 4.67% | 2.91% | 1.91% | 2.05% | 1.95% | 1.95% | 1.95% | — |
Revenue per Share |
17.38 | 14.54 | 14.20 | 12.26 | 9.39 | 8.52 | 8.20 | 6.21 | — |
Operating CF per Share |
1.34 | 0.92 | 0.69 | 0.43 | 0.53 | 0.41 | 0.25 | 0.05 | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.01) | 0.00 | (0.06) | 0.00 | — |
Free Cash Flow per Share |
1.34 | 0.92 | 0.69 | 0.43 | 0.53 | 0.40 | 0.19 | 0.05 | — |
Cash per Share |
3.93 | 4.11 | 3.34 | 3.14 | 3.11 | 0.88 | 0.49 | 0.00 | — |
Shareholders Equity per Share |
6.47 | 5.72 | 5.20 | 4.69 | 4.37 | 1.50 | 0.00 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
6.47 | 5.72 | 5.20 | 4.69 | 4.37 | 1.50 | 0.00 | 0.00 | — |
Free Cash Flow |
163.40 | 109.28 | 80.67 | 47.09 | 54.51 | 38.51 | 18.65 | 5.25 | — |
Working Capital |
342.48 | 385.68 | 313.85 | 287.69 | 256.22 | 43.15 | 14.38 | — | — |
Capital Expenditures |
— | — | (0.11) | (0.10) | (0.55) | (0.38) | (5.71) | (0.22) | — |
Net Current Asset Value |
332.57 | 382.49 | 308.29 | 278.20 | 210.48 | 4.77 | 129.60 | — | — |
EV/EBIT |
71.52 | 110.39 | 116.70 | 0.00 | 0.00 | 80.55 | 80.55 | 80.55 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | — |
Price to Operating Income |
84.62 | 137.46 | 134.03 | 0.00 | 0.00 | 82.40 | 82.40 | 82.40 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
19.66 | 5.85 | 2.81 | 1.55 | 0.58 | 0.41 | 0.31 | 0.00 | — |
Cash ROIC |
12.86% | 9.30% | 8.09% | 5.43% | 6.79% | 14.75% | 21.53% | 0.00% | — |
Accounts Receivable Turnover |
5.92 | 5.72 | 6.90 | 8.84 | 8.93 | 9.26 | 8.91 | 0.00 | — |
Accounts Payable Turnover |
21.40 | 22.31 | 27.04 | 24.73 | 21.18 | 12.04 | 18.03 | 15.12 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
18.47 | 19.19 | 14.11 | 15.78 | 18.60 | 19.51 | 42.10 | (1.92) | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
358.54 | 303.47 | 240.19 | 153.50 | 108.26 | 88.23 | 88.23 | — | — |
Average Payables |
89.40 | 69.91 | 55.33 | 49.41 | 42.62 | 61.02 | 39.82 | 39.82 | — |
Average Assets |
1,252.58 | 1,067.84 | 896.36 | 739.59 | 507.67 | 164.48 | 0.00 | — | — |
Average Common Equity |
737.20 | 645.42 | 563.22 | 484.62 | 296.92 | 126.93 | 128.48 | — | — |
Columns are period end dates · fundamentals updated 5 Nov 2026